Document is current
Any future updates will be listed below
-
Authors
Huang, Zongjian
Shi, Nan
Luo, Zhenqiu
Chen, Fangfang
Feng, Xunwei
Lai, Yongjing
Li, Jian
Yi, Xiang
Xia, Wei
Tang, Anzhou
-
Funding
Funding for this research was provided by:
Innovation Project of Guangxi Graduate Education (YCBZ2024120, YCSW2024267)
The National Natural Science Foundation of China (82260519)
the National Natural Science Foundation of China (32060132)
National Natural Science United Foundation of China (U21A20371)
Guangxi Clinic Medicine Research Center of Nasopharyngeal Carcinoma (GuikeAD20297078)
Guangxi Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor (GKE-ZZ202225)
- License Information
-
More Information
Article History
Received: 29 October 2024
Accepted: 5 March 2025
First Online: 4 April 2025
Declarations
:
: All animal experiments were performed in strict accordance with the ARRIVE guidelines and Basel Declaration ethical standards, with particular emphasis on the “3R” principle (Replacement, Reduction, and Refinement). The study protocols were reviewed and approved by the Institutional Review Board of the Guangxi Medical University (No. 202201010).
: Not applicable.
: The authors declare no competing interests.
